GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

NSPR · Jun 30, 2026

InspireMD, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001493152-26-038438General Corporate

Capex intensity50thOwn-history percentile · N=10

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

18.63% · OPTIONAL · VALID

Operating cash generation0thOwn-history percentile · N=10

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-615.19% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

-0.39% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure70thOwn-history percentile · N=10

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

152.51% · OPTIONAL · VALID

Gross margin0thOwn-history percentile · N=10

Evidence method

Level · gp.fundamentals.gross_margin

-43.70% · CORE · VALID

Operating margin0thOwn-history percentile · N=10

Evidence method

Level · gp.fundamentals.operating_margin

-815.64% · CORE · VALID

R&D intensity90thOwn-history percentile · N=10

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

242.52% · OPTIONAL · VALID

SBC intensity20thOwn-history percentile · N=10

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

125.24% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History11 statesHistory building

Dec 31, 20230/7 normalizedLevel 3 Mar 31, 20240/7 normalizedLevel 3 Jun 30, 20240/7 normalizedLevel 3 Sep 30, 20240/7 normalizedLevel 3 Dec 31, 20240/8 normalizedLevel 3 Mar 31, 20250/8 normalizedLevel 3 Jun 30, 20250/8 normalizedLevel 3 Sep 30, 20250/8 normalizedLevel 3 Dec 31, 20257/8 normalizedLevel 3 Mar 31, 20267/8 normalizedLevel 3 Jun 30, 20267/8 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Increased

Previous: 5.71%
Current: 18.63%
Delta: 12.92%

Cash Generation Decreased

Previous: -363.07%
Current: -615.19%
Delta: -252.12%

Growth Decreased

Previous: 122.24%
Current: -0.39%
Delta: -122.63%

Inventory Pressure Increased

Previous: 89.35%
Current: 152.51%
Delta: 63.17%

Margin Decreased

Previous: 20.22%
Current: -43.70%
Delta: -63.92%

Profitability Decreased

Previous: -411.36%
Current: -815.64%
Delta: -404.28%

R And D Intensity Increased

Previous: 140.17%
Current: 242.52%
Delta: 102.35%

Sbc Intensity Increased

Previous: 61.95%
Current: 125.24%
Delta: 63.29%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Compared To · Surgical & Medical Instruments & Apparatus peers →Transitioned To · NSPR Fundamental State →Transitioned To · NSPR CAPEX_INTENSITY_INCREASED →Transitioned To · NSPR CASH_GENERATION_DECREASED →Transitioned To · NSPR GROWTH_DECREASED →Transitioned To · NSPR INVENTORY_PRESSURE_INCREASED →Transitioned To · NSPR MARGIN_DECREASED →Transitioned To · NSPR PROFITABILITY_DECREASED →Transitioned To · NSPR R_AND_D_INTENSITY_INCREASED →Transitioned To · NSPR SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.